Table 6 Odds ratios for non-Hodgkin's lymphoma in relation to latent and lytic antibodies against KSHV

From: A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein–Barr virus in adults with human immunodeficiency virus-1

 

Unadjusted

Adjusted for CD4 a

Titre

Number of cases/controls N =67

OR (95% CI)

Number of cases/controls N =50

OR (95% CI)

Latent anti-KSHV antibodies

 Negative

57/61

1.0–

43/44

1.0–

 Positive

10/6

1.8 (0.6–5.4)

7/6

1.2 (0.3–5.3)

  

χ2(1)=1.2, P=0.3

 

χ2(1)=0.04, P=0.8

 

Unadjusted

Adjusted for CD4 a

Titre

Number of cases/controls N =66

OR (95% CI)

Number of cases/controls N =49

OR (95% CI)

Lytic anti-KSHV antibodies

 Negative

60/62

1.0–

44/45

1.0–

 Positive

6/4

1.5 (0.4–5.3)

5/4

0.5 (0.1–2.7)

  

χ2(1)=0.4, P=0.5

 

χ2(1)= 0.6, P=0.4

  1. aAdjusted for CD4 count (<200, 200–500, 500+); the number of participants is fewer because some did not have a CD4 count available from around the time the blood was collected.
Back to article page